Bortezomib Comes to the Rescue: Comment on the Article by Nachmias et al. Entitled "A Bortezomib-Based Protocol Induces a High Rate of CR with Minor Toxicity in Adult Patients with Relapsed/Refractory ALL"

Acta Haematol. 2018;140(4):247-249. doi: 10.1159/000494425. Epub 2018 Nov 13.

Authors

Yoav H Messinger¹, Bruce C Bostrom²

Affiliations

¹ Cancer and Blood Disorders, Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota, USA, yoav.messinger@childrensmn.org.
² Cancer and Blood Disorders, Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota, USA.

PMID: 30423549
DOI: 10.1159/000494425

No abstract available

Publication types

Editorial
Comment

MeSH terms

Adult
Boronic Acids*
Bortezomib
Humans
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
Pyrazines
Remission Induction

Substances

Boronic Acids
Pyrazines
Bortezomib